Skip to main content

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Metformin in Children With Relapsed or Refractory Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Metformin in Children With Relapsed or Refractory Solid Tumors

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus

A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 253
  • Page 254
  • Page 255
  • Page 256
  • Page 257
  • Page 258
  • Page 259
  • Page 260
  • Page 261
  • …
  • Next page Next
  • Last page Last
Subscribe to